Bio-Path Holdings, Inc. short interest in 2018
In 2018, Bio-Path Holdings, Inc.'s disclosed short interest ran from 1.58% of shares outstanding on 12 Jan 2018 to 0.94% on 31 Dec 2018, a change of -0.64 percentage points. The year's high was 4.81% on 30 Apr 2018 and its low 0.73% on 31 Jan 2018, averaging 2.82% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.90 days on 31 Jul 2018. Full history: Bio-Path Holdings, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2018 in figures
- Start of year
- 1.58% (12 Jan 2018)
- End of year
- 0.94% (31 Dec 2018)
- Change
- -0.64 pp
- High
- 4.81% (30 Apr 2018)
- Low
- 0.73% (31 Jan 2018)
- Average
- 2.82%
- Highest days to cover
- 26.90 (31 Jul 2018)
- SEC filings marked
- 8
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 1.58% | 2.94 | |
| 31 Jan 2018 | 0.73% | 1.00 | |
| 29 Mar 2018 | 1.99% | 4.06 | |
| 13 Apr 2018 | 4.55% | 1.00 | 10-K filed, results (8-K) |
| 30 Apr 2018 | 4.81% | 2.43 | |
| 15 May 2018 | 4.67% | 10.69 | 10-Q filed |
| 31 May 2018 | 4.36% | 11.40 | results (8-K) |
| 15 Jun 2018 | 4.02% | 24.64 | |
| 29 Jun 2018 | 3.99% | 12.30 | |
| 13 Jul 2018 | 3.78% | 13.93 | |
| 31 Jul 2018 | 3.27% | 26.90 | |
| 15 Aug 2018 | 2.93% | 20.56 | 10-Q filed, results (8-K) |
| 31 Aug 2018 | 2.56% | 12.39 | |
| 14 Sep 2018 | 2.13% | 10.11 | |
| 28 Sep 2018 | 1.56% | 1.12 | |
| 15 Oct 2018 | 2.61% | 1.00 | |
| 31 Oct 2018 | 2.83% | 2.36 | |
| 15 Nov 2018 | 1.96% | 3.72 | 10-Q filed, results (8-K) |
| 30 Nov 2018 | 2.62% | 1.00 | |
| 14 Dec 2018 | 1.40% | 1.00 | |
| 31 Dec 2018 | 0.94% | 1.00 |
See also: Bio-Path Holdings, Inc.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.